Scope and epidemiology of cancer therapy-induced oral and gastrointestinal mucositis
- PMID: 15038511
- DOI: 10.1053/j.soncn.2003.10.002
Scope and epidemiology of cancer therapy-induced oral and gastrointestinal mucositis
Abstract
Objective: To discuss the scope and epidemiology of cancer therapy-induced mucositis.
Data source: Peer-reviewed articles and book chapters.
Conclusion: Mucositis is a frequent and costly complication of cancer treatment. The risk of cancer therapy-induced mucositis varies depending on a number of patient- and treatment-related factors.
Implications for nursing practice: An awareness of the risk factors associated with mucositis will allow nurses to identify cancer patients at greatest risk and incorporate supportive care measures into their management plans.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
